Full Text
PCN44 COST UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR BREAST CANCER IN THE UK

Abstract

Authors

P Booth R Dubois QV Doan Z Liu

Back to Volume 9, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×